The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes

Frias, JP; Bastyr, EJ; Vignati, L; Tschop, MH; Schmitt, C; Owen, K; Christensen, RH; DiMarchi, RD

DiMarchi, RD (reprint author), Novo Nordisk Res Ctr Indianapolis, Indianapolis, IN 46241 USA.

CELL METABOLISM, 2017; 26 (2): 343

Abstract

Unimolecular dual incretins derived from hybridized glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) sequences have ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索